Online adaptive radiotherapy using integrated vendor platforms: workflow timings using Radixact® and Raystation.
Samira Shire, United Kingdom | ESTRO | 2026
Development and implementation of online adaptive radiotherapy (oART) using a Radixact delivery platform in combination with the RayStation TPS
Irena Blasiak-Wal, United Kingdom | ESTRO | 2026
Initial clinical experience of RayStation-based online adaptive RT using Radixact for endometrial cancer.
Irena Blasiak-Wal, United Kingdom | ESTRO | 2026
How low can we go? Margin validation of CT-based online adaptive radiotherapy (oART) in the post operative treatment of endometrial and cervix cancer
Benjamin J Thomas | ESTRO | 2026
One-year cumulative toxicity in 25 prostate cancer patients treated with single fraction (24 Gy) urethra-sparing radiosurgery (PRO-FAST NCT05936736 )
Andrei Fodor, Italy | ESTRO | 2026
Cyberknife UH-SBRT for localized Prostate cancer and DIL: preliminary report of acute and late side effects of the prospective PRO-SPEED trial
Karl Amin, Italy | ESTRO | 2026
EARLY FINDINGS FROM THE STARR (NCT05455736) TRIAL:STEREOTACTIC SALVAGE RADIOTHERAPY FOR MACROSCOPIC RECURRENCE IN THE PROSTATE BED POST-PROSTATECTOMY
Niccolo’ Bertini | ESTRO | 2026
Impact of alternating-day fractionation on treatment outcome and toxicity in CyberKnife prostate SBRT
Michaela Jindráková, Czech Republic | ESTRO | 2026
Stereotactic body radiation therapy for intermediate-risk prostate cancer: efficacy and toxicity
María Dolores Espinosa Cuesta | ESTRO | 2026
DVH-based analysis of genitourinary side effects in robotic SBRT prostate treatments
David Sevillano, Spain | ESTRO | 2026
Planning, patient QA and image-guidance aspects of single-fraction, one-Day robotic SBRT for localized prostate cancer.
SARA BROGGI, Italy | ESTRO | 2026
Cyberknife Radiosurgery of Prostate Cancer – Results for 200 Patients
Sebastian Exner, Germany | ESTRO | 2026
Correlations of biochemical and clinical outcomes with 10-year results after robotic stereotactic body radiotherapy for localized prostate cancer
Kim JS , Park Y, Park HJ, Jang WI, Jeong BK, Kim H-J, Chang AR. Radiat Oncol. 2025 Oct 23;20(1):157. doi: 10.1186/s13014-025-02739-z. PMID 41131547
Stereotactic Radiotherapy Boost in Locally Advanced Cervical Carcinoma Patients (STARBACS): Up-to-Date Results of a Phase II, Single Arm, Monoinstitutional Study
Silvana Parisi et al. | ASTRO | 2025
Clinical Application of Simultaneous Integrated Boost in Stereotactic Body Radiotherapy for Large-Volume Tumors: A Single-Center Retrospective Study
Min Zhao et al. | ASTRO | 2025
Frameless Robotic Radiosurgery System Stereotactic Body Radiation Therapy (SBRT) Dose Escalation Prostate Cancer Trial (CK-DESPOT) for Unfavorable Intermediate and High-Risk
Mark Nguyen et al. | ASTRO | 2025
Urethra Sparing in Robotic SBRT for Localized Prostate Cancer with Simultaneous Focal Boost to MR-Defined High PI-RADS Score Intra-Prostatic Lesions: A Dosimetric Analysis
Hong Xiang et al. | ASTRO | 2025
Reirradiation with SBRT in Radiorecurrent Prostate Cancer: Impact on Disease Control and Quality of Life Outcomes
Papaiah Sridhar et al. | ASTRO | 2025
PSMA Based Dose Escalation to Dominant Intraprostatic Lesion (DIL) in Localized Carcinoma Prostate Treated with Stereotactic Body Radiotherapy
Papaiah Susheela Sridhar et al. | ASTRO | 2025
Optimizing PTV Generation and Comparison of OAR Dosimetry with Different Rectal Spacers in Patients Treated with HDR-Like Prostate SBRT
Emily Hollis et al. | ASTRO | 2025
